CV Board Leadership

Board of Directors

The proposed American Board of Cardiovascular Medicine is governed by a Board of Directors comprising cardiovascular professionals spanning the field of cardiology. The following 15 directors will guide the new Board and be responsible for strategically developing and implementing the initial certification and supporting continuous certification programs once a decision by the American Board of Medical Specialties has been made.

Jeffrey T. Kuvin, MD (President)
Jeffrey T. Kuvin, MD, is the Lorinda and Vincent de Roulet professor of medicine and chair of cardiology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, chair of cardiology at North Shore University Hospital and Long Island Jewish Medical Center, co-director of the Sandra Atlas Bass Heart Hospital at North Shore University Hospital, senior vice president of cardiology at Northwell, and co-executive director of Northwell’s Cardiovascular Institute.

Kuvin is a member of the ACC’s Board of Trustees and is an associate editor of the Journal of the American College of Cardiology. He is past chair of the ACC’s Annual Scientific Sessions, past chair of ACC’s Lifelong Learning Oversight Committee, initial developer and past chair of ACC’s Fellow In-Training Examination, and chair of the ACC’s Continuous Cardiovascular Competency Work Group which developed and implemented the initial strategies for a new cardiovascular board.

Kuvin holds a bachelor’s degree in Near East and North African Studies from the University of Michigan and medical degree from Emory University. He completed his internal medicine internship, residency, chief residency, and cardiology fellowship at Tufts Medical Center.

Mark H. Drazner, MD (Treasurer)
Mark H. Drazner, MD, MSc, is a professor of Internal Medicine with tenure, Clinical Chief of Cardiology, and holds the James M. Wooten Chair in Cardiology at the University of Texas Southwestern Medical Center (UTSWMC).

Drazner previously served as the Medical Director of the Advanced Heart Failure/LVAD/Transplant section at UTSWMC. He was president of the Heart Failure Society of America from 2021-2022. He has published extensively in the field of heart failure and has extensive experience with matters related to subspeciality training.

He completed his medical education at Washington University in St. Louis and his internal medicine training at UTSWMC where he was chief resident. He completed a cardiology fellowship at Duke University Medical Center, and then a Cardiomyopathy/Transplant Cardiology fellowship at Brigham and Women’s Hospital. He subsequently received a Master of Science in Epidemiology from the Harvard School of Public Health.

Jodie L. Hurwitz, MD (Secretary)
Jodie L. Hurwitz, MD, is the director of electrophysiology at North Texas Heart Center and the director of the electrophysiology lab at Medical City Heart and Spine Hospital in Dallas.

Dr. Hurwitz is published widely and participates extensively in clinical and device trials and has been named several times to the Best Doctors in Dallas and Texas Super Doctors.

She is president of the Heart Rhythm Society (HRS) and president of the North Texas Electrophysiology Society. She has been involved in multiple HRS activities, including the Women’s Leadership Initiative, serving as the HRS representative for the American Medical Association, and chairing the Membership Committee. She was also on the ABIM writing committee for Cardiac Electrophysiology Boards for five years.

Hurwitz received her medical degree from Albert Einstein College of New York. She completed her internship and residency at Parkland Hospital in Dallas, TX, and her fellowship in cardiology and electrophysiology at Duke University Medical School.

Kathryn “Katie” Berlacher, MD
Katie Berlacher, MD, is the medical director of the Magee Women’s Heart Program, the program director of cardiovascular fellowship, and is an assistant professor of medicine at the University of Pittsburgh School of Medicine

Berlacher received her medical degree from The Ohio State University and completed her residency and fellowship at the University of Pittsburgh Medical Center. She is certified in cardiovascular disease by the American Board of Internal Medicine and adult echocardiography by the National Board of Echo. Her clinical interests include women’s heart disease, including pregnancy and heart disease risks, as well as medical education. She has published numerous articles in peer-reviewed journals and is a member of the American College of Cardiology and the American Heart Association.

Renee Bullock-Palmer, MD
Renee Bullock-Palmer, MD, is the director of Non-Invasive Cardiac Imaging and director of the Women’s Heart Center at Deborah Heart and Lung Center in New Jersey. In addition, she’s a clinical associate professor in the Department of Medicine within the Division of Cardiology at Thomas Jefferson University in Philadelphia, PA.

A multimodality imaging expert, Bullock-Palmer completed an Advanced Multimodality Imaging fellowship at St. Luke’s-Roosevelt Hospital Center of Columbia University, College of Physicians and Surgeons in New York, and obtained COCATS level III training in nuclear cardiology, echocardiography and cardiovascular CT. She is board certified in Adult Congenital Heart disease, Cardiovascular Medicine, Cardiovascular CT, Nuclear Cardiology, Echocardiography and Internal Medicine. Other areas of clinical interest include women’s heart health, cardiac amyloidosis and adult congenital heart disease.

Dr. Bullock-Palmer is an active leader within the American College of Cardiology (ACC), American Heart Association, American Society of Nuclear, American Society of Echocardiography (ASE) and the Society of Cardiovascular Computed Tomography (SCCT). She also sits on the board of directors of the Intersocietal Accreditation Commission (IAC)- CT Board.

Peter L. Duffy, MD
Peter L. Duffy, MD, is an interventional cardiologist practicing at McLeod Seacoast Hospital in Little River, SC, as a full time Locum Tenens Interventional Cardiologist focusing on cardiovascular service line development and cath lab quality.

He has published extensively on best practices for radial artery interventions, guidelines for clinical excellence in proctoring new technologies, performing PCI in ambulatory surgical centers, optimizing resource utilization in the cath lab, and integrating appropriate use criteria into daily practice. He has performed over 12,000 diagnostic and interventional procedures.

Duffy has served in leadership roles within both SCAI and ACC, most recently serving as treasurer of SCAI from 2018-2021 and on the ACC’s NCDR Oversight Committee (formerly Management Board). He also served on the CMS Hospital Outpatient Payment Program Board and on CMS’s Ambulatory Surgical Center/Hospital Outpatient Department Measure Development Committee.

Duffy completed his fellowship in Cardiovascular Diseases at Georgetown University/VA Medical Center in Washington, DC, in 1985. He earned his Master in Medical Management (MMM) degree from Carnegie Mellon University in 2009 focusing on health care quality and physician leadership. He was awarded the Certified Physician Executive (CPE) designation by the American Academy for Physician Leadership in 2012. He holds board certifications in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology.

David P. Faxon, MD
David P. Faxon, MD, is the past associate chief of cardiology, clinical director of ambulatory cardiovascular services and vice chair of medicine at the Brigham and Women’s Hospital (BWH) in Boston, MA.

Prior to his current roles, Faxon started his career at Boston University Medical Center in 1980, where he directed the cath lab and established one of the first angioplasty programs in the U.S. From 1993-2000, he was chief of cardiology and professor of medicine at the University of Southern California and then went on to serve as chief of cardiology and professor of medicine at the University of Chicago until 2006. Upon returning to Boston, Faxon was chief of cardiology at the Boston VA Healthcare System and vice chair of medicine at BWH.

Faxon is past president of SCAI (1997-1998), AHA (2001-2002) and the Vascular Disease Foundation (2013-2015). He has also served on numerous ACC and AHA committees and has been a member of the ABIM Cardiovascular Board and the ACGME Residency Review Committee in Internal Medicine. He was on the Board of the Alliance for a Healthy Generation from 2006 to 2022.

A graduate of Hamilton College, Faxon received his medical degree from Boston University School of Medicine. He did his internship and residency at Dartmouth Hitchcock Medical Center and his Cardiology Fellowship at Boston University Medical Center.

Edward T. A. Fry, MD
Edward T. A. Fry, MD, is chair of the Ascension National CV Service Line at Ascension St. Vincent in Indianapolis, IN.

He is a past president of ACC (2022-2023) and past president and governor of the IN Chapter of the ACC. He has held many leadership positions within the ACC, serving on the Board of Trustees, Board of Governors, MedAxiom Board of Managers and numerous other work groups, task forces and committees. He has been a presenter, moderator, and session chair at multiple national and international meetings and has published over 60 manuscripts. He is an Honorary Fellow of the Royal College of Physicians Ireland.

Fry attended medical school at Washington University School of Medicine in St. Louis, MO, and completed his residency in internal medicine at Barnes-Jewish Hospital. He completed a two-year cardiovascular research fellowship focused on pharmacokinetics/pharmacodynamics of native and genetically modified plasminogen activators. He also completed a general cardiology fellowship at Washington University in St. Louis, where he then served as assistant professor and medical director of the cardiac transplant program before completing an interventional cardiology fellowship at Ascension St. Vincent Hospital – Indianapolis.

Judith S. Hochman, MD
Judith S. Hochman, MD, is senior associate dean for clinical sciences, founding co-director of the NYU Clinical and Translational Science Institute (CTSI), Harold Snyder Family Professor and Associate Director, Division of Cardiology, and Director, Cardiovascular Clinical Research Center at NYU Langone Health/NYU Grossman School of Medicine.

Hochman was a CCU and step-down unit director for 20 years. She has a successful record in leading large collaborative programs and in training the next generation. As one of two founding CTSI Directors, she has a leadership role in overseeing education and training. She developed and led, as Study Chair, NHLBI-funded international trials testing the role of revascularization in ischemic heart disease, from cardiogenic shock to stable coronary disease. These trials led to new/revised recommendations in Practice Guidelines.

She is the recipient of numerous awards, most recently being recognized with the European Society of Cardiology 2020 Rene Laennec Lectureship and the 2023 AHA CLCD Distinguished Achievement Award and Distinguished Scientist Award.

Dr. Hochman received her MA in cellular and developmental biology from Harvard and MD from Harvard Medical School.

Esther Kim, MD, MPH
Esther Kim, MD, MPH, is a cardiologist and vascular medicine specialist and is currently the director of the Center for Women’s Cardiovascular Health, Academic Chief of Cardiology, and the Izard Family Distinguished Chair in Cardiovascular Medicine at Atrium Health Sanger Heart and Vascular Institute in Charlotte, NC.

She received her undergraduate and medical degrees at Duke University and a master’s degree in public health at the University of North Carolina at Chapel Hill. She completed internal medicine residency at Johns Hopkins Hospital and fellowships in cardiovascular medicine and vascular medicine at the Cleveland Clinic. Her clinical interest is in cardiovascular disease in women, uncommon arterial disorders including spontaneous coronary artery dissection (SCAD) and fibromuscular dysplasia (FMD).

Kim an active leader in multiple national cardiovascular societies, including the American Heart Association, and is currently a member of the Board of Directors of the Intersocietal Accreditation Commission Vascular Testing Division and the treasurer for the Society for Vascular Medicine.

Michelle Maya Kittleson, MD
Michelle Maya Kittleson, MD, is professor of medicine at Cedars-Sinai and director of education in heart failure and transplantation at the Smidt Heart Institute.

Kittleson has served as Interim Editor-in-Chief of the Journal of Heart and Lung Transplantation, on writing committees for the ACC/AHA Hypertrophic Cardiomyopathy Guidelines and the ACC/AHA/HFSA HF Guidelines, co-editor-in-chief for the ACC Heart Failure Self-Assessment Program, and on the Board of Directors for HFSA. Her essays have appeared in the New England Journal of Medicine, Annals of Internal Medicine, and JAMA Cardiology and poems in JAMA and Annals of Internal Medicine. Her book, Mastering the Art of Patient Care, is available from Springer publishing.

She graduated from Harvard College and received her medical degree from Yale University. She completed residency training at Brigham and Women’s Hospital and cardiology fellowship at Johns Hopkins, where she also received a PhD in Clinical Investigation. 

Daniel M. Kolansky, MD
Daniel M. Kolansky, MD is professor of medicine at the Perelman School of Medicine at the University of Pennsylvania, director of the Cardiac Care Unit, and the associate chief for clinical affairs for the Cardiovascular Division at the Hospital of the University of Pennsylvania.

Kolansky has a long interest in quality metrics in Interventional Cardiology and has contributed to the development of the SCAI Core Curriculum in quality assessment for Interventional Fellowship Training programs, as well as SCAI Expert Consensus Statements on Best Practices in the Cath Lab and on Length of Stay following PCI. He has published widely on numerous topics in interventional cardiology and is a member of the SCAI Board of Trustees and sits on the JSCAI Editorial Board.

Kolansky is a graduate of Stanford University and the Yale School of Medicine. He completed his Internship, Residency, and Fellowship in Cardiology and Interventional Cardiology at Yale-New Haven Hospital.

Gregory F. Michaud, MD
Gregory F. Michaud, MD is the clinical director of the Demoulas Center for Cardiac Arrhythmias at Massachusetts General Hospital and faculty at Harvard Medical School.

He treats patients with complex arrhythmias using catheter ablation and is credited with at least four separate pacing maneuvers that are now part of core testing during specialty Board examinations for cardiac electrophysiology. As the director of the Center for the Advanced Management of Atrial Fibrillation at Brigham and Women’s Hospital, he played a pivotal role in developing better ablation strategies for the treatment of atrial fibrillation.

Michaud speaks at national and international academic conferences on his work in arrhythmia diagnosis and treatment and has authored or co-authored numerous manuscripts. He was recently co-director of the Heart Rhythm Society board review course for clinical cardiac electrophysiology, inaugural chair of the Core Concepts Committee and a member of the Program Committee for the Heart Rhythm Society Scientific Sessions.

He received his MD degree from the University of Maryland in Baltimore. He completed his medical training at Boston University Hospital and Cardiac Electrophysiology Fellowship at Tufts University.

William H. Roach, Jr.
William H. Roach, Jr. is a retired capital partner of the global law firm of McDermott Will & Emery LLP, where he represented primarily academic medical centers and regional and national nonprofit hospital systems in corporate, governance, merger/acquisitions, physician/faculty arrangements, and a wide range of health industry operations.

He is a past director and chair of the national board of the American Heart Association and a past chair of the Strategic Advisory Committee of Voices for Healthy Kids, the national advocacy coalition supported by the AHA and Robert Wood Johnson Foundation. Roach has served in numerous national and local bar associations and is a former president and a founding director of the Illinois Association of Hospital Attorneys.

He earned a BA from Columbia University, a JD from Vanderbilt University School of Law, and an MS from the Health Law Program of the University of Pittsburgh. At Vanderbilt, he was a Patrick Wilson Scholar. He served as an Illinois licensed Emergency Medical Technician for several years and is a Vietnam War veteran, having served as an officer in the U.S. Navy on active and reserve duty.

Karen Stout, MD
Karen Stout, MD, is a professor of medicine and adjunct professor of pediatrics at the University of Washington, where she serves as the associate division head for the Division of Cardiology and Service Chief for Cardiology at the University of Washington Medical Center (UWMC). She is founder of the Adult Congenital Heart Disease (ACHD) Program at UWMC and Seattle Children’s Hospital.

Stout earned her medical degree at the University of Arizona and completed her general cardiology fellowship at the University of Washington, followed by additional Congenital Heart Disease training at Seattle Children’s. She is board certified in both ACHD and Cardiovascular Disease. Her clinical interests and expertise include adult congenital heart disease, echocardiography and pregnancy and heart disease. Her research interests include long-term outcomes of adults with congenital heart disease.

Stout has held many leadership roles within the ACHD and pediatric cardiology community at the American College of Cardiology, American Heart Association and the Adult Congenital Heart Association. She has also served on the Cardiology Board of the American Board of Internal Medicine and had served for 11 years on the Writing Committee of the ACHD Board Exam of the ABIM, beginning at its inception. She was also elected chair of the UWMC Appointment and Promotions Council at the University of Washington.

Last Updated: July 2024

©2024, American College of Cardiology Foundation, American Heart Association, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions